Skip to content

David A. Bender

Washington University in St. Louis

2 papers in the library · 15 citations · publishing 2023-2026

Papers

Psilocybin desynchronizes brain networks

medRxiv August 24, 2023 Subha Subramanian, Demetrius Perry, Caterina Gratton et al. 14 citations preprint

Psilocybin disrupts connectivity across cortical networks and subcortical structures, producing more than three-fold greater acute changes in functional networks than methylphenidate. These changes are driven by desynchronization of brain activity across spatial scales, strongest in the default mode network (DMN), which is connected to the anterior hippocampus and thought to create our sense of self. Performing a perceptual task reduces psilocybin-induced network changes, suggesting a neurobiological basis for grounding during psychedelic therapy. Psilocybin induces a persistent decrease in functional connectivity between the anterior hippocampus and cortex (and DMN in particular), lasting for weeks but normalizing after six months. This persistent suppression of hippocampal-DMN connectivity represents a candidate neuroanatomical and mechanistic correlate for psilocybin's pro-plasticity and anti-depressant effects.

Trends in the psychedelic renaissance: applying artificial intelligence to measure media portrayal of psychedelic drugs in the 21st century

BJPsych Open February 12, 2026 David A. Bender, Holly Dunn, Amanda Pekau et al. 1 citation

From 2000 to 2025, media coverage of psychedelic drugs increasingly focused on their therapeutic potential, rising from 13.3% of articles in 2000–2009 to 85.3% in 2020–2025. Overall sentiment was positive, with an average score of 78.5 out of 100. However, negative and neutral coverage has grown since 2020: the proportion of articles with sentiment scores of 65 or below rose from 3.6% in 2020 to 20.9% in 2024, and average sentiment dropped significantly in 2024 compared to 2020–2023. Artificial intelligence sentiment ratings closely matched human ratings.